Cargando…
TNFRSF9 Suppressed the Progression of Breast Cancer via the p38MAPK/PAX6 Signaling Pathway
Worldwide, breast cancer is the most common cancer in females. Endocrine therapy can effectively treat 85% of breast cancer patients, but 15% of patients could only be treated with chemotherapy and surgery, and the prognosis is much worse. Immunotherapy is the novel treatment for breast cancer, wher...
Autores principales: | Liu, Xiaorong, Zhou, Yehui, Qin, Chenglin, Zhu, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256432/ https://www.ncbi.nlm.nih.gov/pubmed/35799609 http://dx.doi.org/10.1155/2022/8549781 |
Ejemplares similares
-
MicroRNA-655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and suppressing the ERK and p38 MAPK signalling pathways
por: Zhang, Min, et al.
Publicado: (2022) -
Bakuchiol Suppresses Inflammatory Responses Via the Downregulation of the p38 MAPK/ERK Signaling Pathway
por: Lim, Hye-Sun, et al.
Publicado: (2019) -
Hypoxia regulates CD9-mediated keratinocyte migration via the P38/MAPK pathway
por: Jiang, Xupin, et al.
Publicado: (2014) -
Dahuang Zhechong Pills Suppress Silicosis Fibrosis Progression via p38 MAPK/TGF-β1/Smad Pathway In Vitro
por: Wu, Li-Juan, et al.
Publicado: (2021) -
Ubiquitin D promotes the progression of rheumatoid arthritis via activation of the p38 MAPK pathway
por: Chen, Hong, et al.
Publicado: (2023)